News & Views

Press Releases

Population Council Research Featured at First Global Maternal Newborn Health Conference, 18–21 October in Mexico City

Council Studies Advance Global Efforts to Keep Women and Children Healthy and Safe

Population Council researchers will present the latest data on access to life-saving innovations and drugs that reduce preventable maternal and newborn deaths, barriers to facility-based childbirth, and the validity of self-reporting maternal and newborn health care indicators at the premiere Global Maternal Newborn Health Conference, 18–21 October in Mexico City.

Convened by the Mexican Secretariat of Health and partners including USAID, the Bill & Melinda Gates Foundation, UNFPA, UNICEF, and others, the conference advances technical knowledge and showcases innovative solutions to improving maternal and newborn health within the post-2015 development framework. Attendees, including technical implementers, policymakers, researchers, and practitioners, come from more than 50 countries. 

Read more

Council Commentary

Population Council Mourns the Death of Family Planning Researcher Tapani Luukkainen

University of Helsinki researcher Tapani Luukkainen, who led the development of Mirena®, the highly effective levonorgestrel-releasing intrauterine system (IUS) died on Monday, September 21. He was 86 years old.

Mirena was approved by the US Food and Drug Administration in 2000 for contraception and later for the treatment of heavy menstrual bleeding.

As a member of the Council’s International Committee for Contraception Research, Dr. Luukkainen also pioneered research to identify innovative contraceptive methods for men and women and strengthened the capacity of clinical research centers in developed and developing countries. He was a giant in the field of contraceptive R&D, a patient yet demanding mentor to many young professionals, and an inspiration for those who hope to make a difference in women's lives through their vision and the quality of their work.

“The Population Council honors Dr. Luukkainen’s contributions to improving the health of women around the world,” said John Townsend, vice president and director of the Population Council’s Reproductive Health program. “We join with the reproductive health and family planning communities in celebrating his accomplishments and mourning his passing.”

From Our Partners

Developing Highly Effective, Long-Acting, and Reversible Contraceptives

As a senior medical advisor for Planned Parenthood Federation of America and a professor of obstetrics and gynecology at Columbia University, I know well the power that family planning can provide for women and couples. With effective contraception that meets their needs and lifestyles, women have the ability to freely decide whether to have children and, if so, when and how many.

Read more

From Our Partners

Engaging Adolescents, Parents, and the Community to Change Inequitable Gender Norms in Rural Nepal

This post is part of a blog series on evidence generated through the Population Council’s RISING program. RISING uses implementation science, evidence review, and organizational grants to build knowledge about what works in adolescent girls programming. The views expressed here are those of the authors and do not necessarily represent the views of the Population Council. Please direct any questions to Brad Kerner.

In Nepal, Save the Children and Georgetown University’s Institute for Reproductive Health (IRH) are piloting and evaluating a package of programs called CHOICES, VOICES, and PROMISES that seek to challenge and change restrictive gender norms among very young adolescents by intervening at the levels of the individual, the family, and the community. The programs were developed by Save the Children in Nepal, where there are high rates of early marriage and gender based violence.

Read more

Council Commentary

Delivering Ideas, Evidence, and Solutions to Improve Lives

Since 1952, the Population Council has been changing the way the world thinks about critical health and development issues. Our biomedical, social science, and public health research in more than 50 countries tests ideas, generates evidence, and delivers solutions leading to more effective policies, programs, and technologies that improve lives around the world.

The Council has a rich history. For more than 60 years, our data have driven decisionmaking. From the start we have given voice and visibility to the world’s most vulnerable people. We increase awareness of the problems they face and offer evidence-based solutions. Around the world, governments, civil society organizations, and international agencies seek our help to understand and overcome obstacles to improving health and promoting development. And we work with partners on every continent to use state-of-the-art biomedical science to develop new contraceptives and products to prevent the transmission of HIV

Read more

Press Releases

New Research from the Population Council Shows Child Marriage Can Be Delayed

New Research from the Population Council Shows Child Marriage Can Be Delayed

Researchers Share Findings and Recommendations for Ending Child Marriage in Sub-Saharan Africa

WASHINGTON, DC (12 August 2015) — Today the Population Council released new evidence on what works to delay the age of marriage for extremely vulnerable girls in sub-Saharan Africa. Researchers also shared rarely available data on the cost of interventions that were tested, and issued recommendations for policymakers, donors, and organizations concerned about child marriage.

Each year, more than 14 million girls around the world get married before the age of 18. In sub-Saharan Africa, more than 1 in 10 girls are married before the age of 15. Four in ten are married before the age of 18. In some “hotspots,” such as the areas in which the Population Council’s study was conducted, prevalence of child marriage is even higher.

Read more

Press Releases

Results from New Study of Council’s Investigational One Year Ring Published in PLOS ONE

NEW YORK (12 August 2015)—A study published today in PLOS ONE assessed effects of the Population Council’s investigational one-year reusable contraceptive vaginal ring (CVR) on the incidence of vaginal infections and vaginal microflora. The study demonstrated that use of the CVR for up to 13 cycles presented no increased risk of infection, nor did it disrupt the balance of microbes in the vagina.

The one-year reusable CVR contains Nestorone® and ethinyl estradiol. Nestorone (NES) is an investigational progestin that has been shown in clinical studies to prevent ovulation and pregnancy. Ethinyl estradiol (EE) is an approved, marketed, synthetic version of the female hormone estrogen.

Read more

Media Coverage

Creating Effective Responses to SGBV

Creating Effective Responses to SGBV

Most sexual and gender-based violence (SGBV) programs in East and Southern Africa focus on preventing violence. Fewer focus on meeting the needs of survivors.

The Council leads an innovative network that is creating effective, comprehensive responses to SGBV that bridge the medical, legal, and social-service sectors. A new open-access supplement from BMC Proceedings compiles findings from the Africa Regional SGBV Network's 7 years of innovative research and programming, providing evidence and insights about effective interventions for SGBV survivors in East and Southern Africa and highlighting the ways the network has influenced policy and practice in the region.

Press Releases

Population Council Research on Key Populations, Innovative Treatment and Prevention Models to Be Featured at IAS 2015

IAS 2015, the 8th Conference on HIV Pathogenesis, Treatment and Prevention, is the largest global scientific conference on HIV/AIDS

Population Council experts will present research on HIV treatment adherence among young people and risk among adolescent girls and people with disabilities; the impact of health systems strengthening and task-shifting on HIV prevalence and care; and efforts to increase access to quality HIV services for men who have sex with men at the International AIDS Society Conference, to be held 19–22 July in Vancouver, Canada. With 6,000 HIV professionals in attendance, it is the largest global scientific conference on HIV/AIDS.

Read more